1144 related articles for article (PubMed ID: 10811675)
1. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.
Shepherd FA; Dancey J; Ramlau R; Mattson K; Gralla R; O'Rourke M; Levitan N; Gressot L; Vincent M; Burkes R; Coughlin S; Kim Y; Berille J
J Clin Oncol; 2000 May; 18(10):2095-103. PubMed ID: 10811675
[TBL] [Abstract][Full Text] [Related]
2. Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non-Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy.
Shepherd FA; Dancey J; Ramlau R; Mattson K; Gralla R; O'Rourke M; Levitan N; Gressot L; Vincent M; Burkes R; Coughlin S; Kim Y; Berille J
J Clin Oncol; 2023 May; 41(15):2673-2681. PubMed ID: 37196430
[TBL] [Abstract][Full Text] [Related]
3. Review of two phase III randomized trials of single-agent docetaxel in previously treated advanced non--small cell lung cancer.
Lynch TJ
Semin Oncol; 2001 Jun; 28(3 Suppl 9):5-9. PubMed ID: 11444253
[TBL] [Abstract][Full Text] [Related]
4. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
5. Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Fossella FV; DeVore R; Kerr RN; Crawford J; Natale RR; Dunphy F; Kalman L; Miller V; Lee JS; Moore M; Gandara D; Karp D; Vokes E; Kris M; Kim Y; Gamza F; Hammershaimb L
J Clin Oncol; 2000 Jun; 18(12):2354-62. PubMed ID: 10856094
[TBL] [Abstract][Full Text] [Related]
6. Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline.
Chu Q; Vincent M; Logan D; Mackay JA; Evans WK;
Lung Cancer; 2005 Dec; 50(3):355-74. PubMed ID: 16139391
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens.
Kosmas C; Tsavaris N; Vadiaka M; Stavroyianni N; Koutras A; Malamos N; Onyenadum A; Rokana S; Polyzos A; Kalofonos HP
Cancer; 2001 Dec; 92(11):2902-10. PubMed ID: 11753965
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel for previously treated non-small-cell lung cancer.
Fossella FV
Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):45-51. PubMed ID: 12108897
[TBL] [Abstract][Full Text] [Related]
9. Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial.
Niho S; Kubota K; Goto K; Ohmatsu H; Matsumoto T; Kakinuma R; Nishiwaki Y
Cancer Chemother Pharmacol; 2003 Jul; 52(1):19-24. PubMed ID: 12712259
[TBL] [Abstract][Full Text] [Related]
10. Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancer.
Belani CP; Einzig A; Bonomi P; Dobbs T; Capozzoli MJ; Earhart R; Cohen LJ; Luketich JD
Ann Oncol; 2000 Jun; 11(6):673-8. PubMed ID: 10942054
[TBL] [Abstract][Full Text] [Related]
11. A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC).
Roszkowski K; Pluzanska A; Krzakowski M; Smith AP; Saigi E; Aasebo U; Parisi A; Pham Tran N; Olivares R; Berille J
Lung Cancer; 2000 Mar; 27(3):145-57. PubMed ID: 10699688
[TBL] [Abstract][Full Text] [Related]
12. Activity of docetaxel in platinum-treated non-small-cell lung cancer: results of a phase II multicenter trial.
Gandara DR; Vokes E; Green M; Bonomi P; Devore R; Comis R; Carbone D; Karp D; Belani C
J Clin Oncol; 2000 Jan; 18(1):131-5. PubMed ID: 10623703
[TBL] [Abstract][Full Text] [Related]
13. Weekly docetaxel as II line therapy in non-small cell lung cancer: an interim analysis of a phase II study.
Valerio MR; Russo A; Latteri MA; Modica G; Gulotta G; Armata MG; Bajardi E; Cicero G; Pantuso G; Grassi N; Agosta G; Gebbia N
Lung Cancer; 2001 Dec; 34 Suppl 4():S31-5. PubMed ID: 11742700
[TBL] [Abstract][Full Text] [Related]
14. Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer.
Clark JI; Kancharla K; Qamar R; Fisher S; Hantel A; Panganiban J; Millbrandt L; Albain KS
Lung Cancer; 2001 Nov; 34(2):271-7. PubMed ID: 11679186
[TBL] [Abstract][Full Text] [Related]
15. An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.
Pectasides D; Kalofonos HP; Samantas E; Nicolaides C; Papacostas P; Onyenadum A; Visvikis A; Skarlos D; Fountzilas G
Anticancer Res; 2001; 21(4B):3005-10. PubMed ID: 11712802
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: a review of two phase III trials.
Shepherd FA; Fossella FV; Lynch T; Armand JP; Rigas JR; Kris MG
Semin Oncol; 2001 Feb; 28(1 Suppl 2):4-9. PubMed ID: 11284623
[TBL] [Abstract][Full Text] [Related]
17. Salvage treatment of advanced non-small-cell lung cancer previously treated with docetaxel-based front-line chemotherapy with irinotecan (CPT-11) in combination with cisplatin.
Kakolyris S; Kouroussis C; Kalbakis K; Mavroudis D; Souglakos J; Nvardakis ; Kremos S; Georgoulias V
Ann Oncol; 2000 Jun; 11(6):757-60. PubMed ID: 10942068
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer.
Fossella FV; Lee JS; Shin DM; Calayag M; Huber M; Perez-Soler R; Murphy WK; Lippman S; Benner S; Glisson B
J Clin Oncol; 1995 Mar; 13(3):645-51. PubMed ID: 7884425
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel.
Chen YM; Shih JF; Lee CS; Chen MC; Lin WC; Tsai CM; Perng RP
Lung Cancer; 2003 Feb; 39(2):209-14. PubMed ID: 12581575
[TBL] [Abstract][Full Text] [Related]
20. Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial.
Dancey J; Shepherd FA; Gralla RJ; Kim YS
Lung Cancer; 2004 Feb; 43(2):183-94. PubMed ID: 14739039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]